Gene · 8542
Papers3,519
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,519
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Kidney Disease in the Caribbean-APOL1 Risk Alleles and Emerging Environmental Stressors. | Kidney Int Rep | 2024 | 39081772 | PubTator, text mining | PubMed |
| Single-Ancestry versus Multi-Ancestry Polygenic Risk Scores for CKD in Black American Populations. | J Am Soc Nephrol | 2024 | 39073889 | PubTator, text mining | PubMed |
| The roles and mechanisms of APOL1 in the development of colorectal cancer. | J Gastrointest Oncol | 2024 | 38989412 | PubTator, text mining | PubMed |
| Prejudice and Fear as Influences in Relation to a Successful Organ Donation - Experiences of Immigrants Living in Sweden. | Acta Med Acad | 2024 | 38984698 | PubTator, text mining | PubMed |
| Relevance of repeated analyses of albuminuria and glomerular filtration rate in African children with sickle cell anaemia. | Br J Haematol | 2024 | 38934404 | PubTator, text mining | PubMed |
| Diagnostic Yield of APOL1 p.N264K Variant Screening in Daily Practice. | Kidney Int Rep | 2024 | 38899219 | PubTator, text mining | PubMed |
| High-throughput transcriptome profiling indicates ribosomal RNAs to be associated with resistance to immunotherapy in non-small cell lung cancer (NSCLC). | J Immunother Cancer | 2024 | 38857914 | PubTator, text mining | PubMed |
| Novel Multiplexed Plasma Biomarker Panel Has Diagnostic and Prognostic Potential in Children With Hypertrophic Cardiomyopathy. | Circ Genom Precis Med | 2024 | 38847081 | PubTator, text mining | PubMed |
| APOL1 High-Risk Genotypes and Kidney Disease Risk in Middle-Aged Black Adults: More Questions Than Answers. | Kidney Med | 2024 | 38840847 | PubTator, text mining | PubMed |
| Interferon-γ induces combined pyroptotic angiopathy and APOL1 expression in human kidney disease. | Cell Rep | 2024 | 38838223 | PubTator, text mining | PubMed |
| Systematic evaluation of lecithin:cholesterol acyltransferase binding sites in apolipoproteins via peptide based nanodiscs: regulatory role of charged residues at positions 4 and 7. | PLoS Comput Biol | 2024 | 38805510 | PubTator, text mining | PubMed |
| APOL1 Kidney Risk Variants and Long-Term Kidney Function in Healthy Middle-Aged Black Individuals: The Atherosclerosis Risk in Communities (ARIC) Study. | Kidney Med | 2024 | 38799783 | PubTator, text mining | PubMed |
| Systematic Review of Genetic Modifiers Associated with the Development and/or Progression of Nephropathy in Patients with Sickle Cell Disease. | Int J Mol Sci | 2024 | 38791464 | PubTator, text mining | PubMed |
| A Review of Focal Segmental Glomerulosclerosis Classification With a Focus on Genetic Associations. | Kidney Med | 2024 | 38765809 | PubTator, text mining | PubMed |
| Focal Segmental Glomerulosclerosis Patient Baseline Characteristics in the Sparsentan Phase 3 DUPLEX Study. | Kidney Int Rep | 2024 | 38765567 | PubTator, text mining | PubMed |
| Variant upon variant: kidney-disease risk associated with APOL1 G2 genetic variants is abrogated by the APOL1 p.N264K variant. | Kidney Int | 2024 | 38750901 | PubTator, text mining | PubMed |
| Prevalence of kidney health genetic variants in adults with sickle cell nephropathy. | Br J Haematol | 2024 | 38735682 | PubTator, text mining | PubMed |
| Genetic ancestry, proportion of African ancestry, and apolipoprotein L1 risk variants in kidney recipients. | Am J Transplant | 2024 | 38734416 | PubTator, text mining | PubMed |
| African ancestry-derived APOL1 risk genotypes show proximal epigenetic associations. | BMC Genomics | 2024 | 38714935 | PubTator, text mining | PubMed |
| Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV. | Kidney Int | 2024 | 38697479 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8542/papers?page=16